{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:59:21Z","timestamp":1791269961952,"version":"4.1.0"},"reference-count":9,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T00:00:00Z","timestamp":1207180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Paediatrica"],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aim: To study delivery outcome including presence of infant congenital malformations after maternal use of loperamide in early pregnancy.<\/jats:p><jats:p>Methods: Using the Swedish Medical Birth Register, women reporting the use of loperamide in early pregnancy were compared with other women for the period July 1, 1995\u20132004. Odds ratios (OR) or risk ratios (RR) were estimated after adjustment for some variables, which were associated with the use of loperamide (year of delivery, maternal age, parity, smoking, number of previous miscarriages).<\/jats:p><jats:p>Results: Characteristics of women using loperamide in early pregnancy were identified. An analysis of concomitant drug use indicated that only few of the women had inflammatory bowel disease. The risk of any congenital malformation was increased (OR = 1.43, 95% CI 1.04\u20131.96), based on 43 cases, but no major contributing type could be identified. The risk of hypospadias was significantly increased (RR = 3.2, 95% CI 1.3\u20136.6), based on seven cases. A statistically significant increase was seen also for placenta previa, large for gestational age and caesarean section.<\/jats:p><jats:p>Conclusion: Maternal use of loperamide in early pregnancy may be associated with a moderate risk increase for a malformation in the infant. The finding should be evaluated from other large studies.<\/jats:p>","DOI":"10.1111\/j.1651-2227.2008.00718.x","type":"journal-article","created":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T18:07:06Z","timestamp":1207246026000},"page":"541-545","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Maternal use of loperamide in early pregnancy and delivery outcome"],"prefix":"10.1111","volume":"97","author":[{"given":"Bengt","family":"K\u00e4ll\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra Otterblad","family":"Olausson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,4,3]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"1645","article-title":"Loperamide (R 18,553), a novel type of antidiarrheal agent. 4. Studies on subacute and chronic toxicity and the effect on reproductive processes in rats, dogs, and rabbits","volume":"24","author":"Marsboom R","year":"1974","journal-title":"Arzneim Forsch"},{"key":"e_1_2_7_3_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0749-3797(18)31097-3","article-title":"Risk status and pregnancy outcome among medicaid recipients","volume":"5","author":"Schwethelm B","year":"1989","journal-title":"Am J Prev Med"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1155\/2000\/957649"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.04.049"},{"key":"e_1_2_7_6_2","unstructured":"National Board of Health and Welfare.Centre for Epidemiology. The Swedish Medical Birth Register \u2013 a summary of content and quality.http:\/\/www.sos.se\/FULLTEXT\/112\/2003\u2010112\u20103\/2003\u2010112\u20103.pdf. Accessed 12 May2007."},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JRS-2001-263","article-title":"Monitoring of maternal drug use and infant congenital malformations. Does loratadine cause hypospadias?","volume":"14","author":"K\u00e4ll\u00e9n B","year":"2001","journal-title":"Int J Risk Safety Med"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01719316"},{"key":"e_1_2_7_9_2","unstructured":"National Board of Health and Welfare.Centre for Epidemiology.Registration of congenital malformations in Swedish health registers. (http:\/\/www.socialstyrelsen.se\/Publicerat\/2004\/5120\/2004\u2010112\u20101.htm. Accessed 12 May2007."},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07578.x"}],"container-title":["Acta Paediatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1651-2227.2008.00718.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1651-2227.2008.00718.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T12:59:27Z","timestamp":1738155567000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1651-2227.2008.00718.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,3]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1111\/j.1651-2227.2008.00718.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1651-2227.2008.00718.x","archive":["Portico"],"relation":{},"ISSN":["0803-5253","1651-2227"],"issn-type":[{"value":"0803-5253","type":"print"},{"value":"1651-2227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,3]]},"assertion":[{"value":"2008-04-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}